News from NYU Langone Health
CBS News
There's a growing trend on social media called "supplement stacking" where people take multiple supplements everyday in an effort to boost strength, energy and even hair growth. Rachel Pessah-Pollack, MD, an endocrinologist at NYU Langone Ambulatory Care Lake Success, explains what to know about the trend.
5/10/2026
Medscape
The FDA’s Oncologic Drugs Advisory Committee split its decisions on two cancer drugs from AstraZeneca. The committee backed capivasertib for certain prostate cancer patients, with Neil Vasan, MD, PhD, medical oncologist, director of Translational Research for Breast Â鶹ÊÓƵapp and assistant professor in the Department of Medicine at NYU Grossman School of Medicine, expressing confidence that the treatment's side effects were manageable. However, the committee voted against recommending an investigational drug, camizestrant, for advanced breast cancer due to concerns about the trial's design and lack of an overall survival benefit. Dr. Vasan was among the minority who voted in favor of camizestrant.
5/11/2026
Runner's World
Ray Peralta, PT, DPT, a sports physical therapist at NYU Langone Health, recommends a three-day-a-week marathon training plan to prevent overuse injuries and burnout. He argues that many runners suffer from insufficient recovery on traditional five or six-day plans. His methodology emphasizes three high-quality, purposeful runs per week, supplemented with two days of cross-training and two days of strength training. According to Peralta, this approach allows the body to adapt and build endurance without over-stressing it, making it effective for runners from beginners to advanced athletes seeking personal records.
5/11/2026
Health
A new UnitedHealthcare survey of 100 centenarians identified six key weekly habits for longevity, including eating a healthy diet, strength training, walking, and managing stress. Providing expert commentary, Jordan Weiss, PhD, an assistant professor in the Division of Precision Medicine and Optimal Aging Institute at the NYU Grossman School of Medicine, explained that whole foods support cardiovascular and brain health by lowering inflammation. He also noted that exposure to nature is associated with lower stress hormones, and that healthy habits can bolster longevity by reducing forces that age us, such as chronic inflammation and muscle loss.
Also reporting was:
5/11/2026
Long Island Business News
NYU Langone Health and Metro Physical & Aquatic Therapy have formed a strategic alliance to provide physical, occupational, and speech therapy across Long Island, New York City, Westchester, and Rockland counties. Over 60 Metro PT centers will join NYU Langone’s clinical network. Oren Cahlon, MD, executive vice president, vice dean for clinical affairs and strategy, and chief clinical officer at NYU Langone Health’s Perlmutter Â鶹ÊÓƵapp Center, noted the alliance expands access to seamless care. Jonathan H. Whiteson, MD, chair of the Department of Rehabilitation Medicine and Howard A. Rusk Professor of Rehabilitation Medicine at NYU Grossman School of Medicine, added it expands high-quality rehabilitation. Patients will be connected to NYU Langone’s electronic health record system.
5/11/2026
Urology Times
HistoSonics has submitted a request to the FDA to expand the indication for its Edison Histotripsy System to include the destruction of renal tumors. The submission is supported by data from the #HOPE4KIDNEY study. The trial's principal investigator, William C. Huang, MD, urologic oncologist, chief of urology at Tisch Hospital, codirector of NYU Langone’s Robotic Surgery Center, vice chair of urology, and professor of radiology at the NYU Grossman School of Medicine, noted that the findings highlight the potential of histotripsy to expand treatment options for patients with kidney tumors. The system, which uses focused ultrasound technology, is already authorized for destroying liver tumors and aims to offer a noninvasive, organ-preserving option for patients with renal masses.
Also reporting was: , ,
5/11/2026
World Today News
Researchers at NYU Langone Health and NYU Grossman School of Medicine have developed an experimental compound, RAGE406R, that targets diabetic inflammation to reduce tissue damage, regardless of glucose levels. The new molecule works by blocking the interaction between two proteins, RAGE and DIAPH1, which drives inflammation and cell death. In preclinical mouse models, the therapy accelerated wound closure and reduced organ stress. According to co-senior study author Ann Marie Schmidt, MD, director of Diabetes Research Program at NYU Langone Health and the Dr. Iven Young Professor of Endocrinology at NYU Grossman School of Medicine, the compound addresses the root causes of diabetic complications.
5/11/2026
HealthCentral
A rash is not likely caused by hypertension, according to Gregory Katz, MD, a cardiologist and site director of Inpatient Unit at Tisch Hospital, as well as associate program director in the Internal Medicine Residency Program at NYU Grossman School of Medicine. He notes, however, that a new rash appearing alongside elevated blood pressure warrants a doctor's visit. Dr. Katz explains that some blood pressure medications can cause skin problems. Conversely, certain skin conditions like psoriasis and eczema may increase the risk of high blood pressure, and he recommends regular screening for individuals with these conditions. He also suggests lifestyle changes like exercise, stress reduction, and improved sleep to manage blood pressure.
5/11/2026
Shop TODAY
An article compares red light therapy masks and panels, explaining that the technology uses specific light wavelengths to boost collagen production and reduce inflammation. Mary L. Stevenson, MD, a dermatologist and skin cancer surgeon, and associate professor in NYU Langone's Ronald O. Perelman Department of Dermatology, recommends looking for devices with wavelengths between 630 and 700 nanometers for effectiveness in boosting collagen and speeding up wound healing. The piece also discusses the pros and cons of each device type, noting masks offer convenience while panels provide more power and coverage for larger areas.
5/11/2026
The Transmitter
A new study published in Nature challenges the long-held view of astrocytes as simple support cells for neurons. The work, led by Melissa Cooper, PhD, a postdoctoral fellow and Leon Levy Neuroscience Fellow at NYU Langone Health, reveals that astrocytes form precise, long-range networks spanning the entire brain. Using a newly engineered molecular sensor in mice, the team imaged these networks in three dimensions. They found the networks are highly structured and can rewire in response to sensory changes, remodeling differently than neurons. These findings have implications for understanding brain energy use and neurodegenerative diseases.
5/12/2026
NaturalHealth365
A study from NYU Langone Health, presented at the American Society of Clinical Oncology’s Genitourinary Â鶹ÊÓƵapps Symposium, found microplastics inside prostate cancer tumors. Researchers analyzed prostate tissue from ten men and identified plastic particles in 90% of tumor samples. The study revealed that cancerous tissue contained approximately 2.5 times more plastic than nearby healthy tissue. According to lead researcher Stacy Loeb, MD, urologic oncologist at the Perlmutter Â鶹ÊÓƵapp Center and professor of urology and population health at NYU Grossman School of Medicine, the findings provide important evidence that microplastic exposure may be a risk factor for prostate cancer.
Also reporting was:
5/12/2026
Flow Space
Hidradenitis suppurativa (HS) can feel more disruptive in midlife, even if the disease severity is similar to younger years, due to the context of increased life responsibilities. According to Nicole M. Golbari, MD, MPH, a dermatologist and Mohs micrographic surgeon at NYU Langone Ambulatory Care in Garden City, as well as a clinical assistant professor at NYU Grossman Long Island School of Medicine, hormonal fluctuations during perimenopause, metabolic shifts, and increased systemic inflammation can all influence HS activity. She adds that chronic stress is a measurable trigger that can dysregulate immune function. Dr. Golbari emphasizes that worsening symptoms should not be normalized as part of aging and that treatment should be individualized and comprehensive.
Also reporting was:
5/11/2026
UroToday
A 10-year, multi-institutional clinical trial on stereotactic body radiotherapy (SBRT) for organ-confined prostate cancer found the treatment offers minimal toxicity and favorable relapse-free survival. The study, co-authored by Nima Aghdam, MD, a radiation oncologist and medical director of NYCyberKnife Center at Perlmutter Â鶹ÊÓƵapp Center, and director of Research at the Department of Radiation Oncology at NYU Langone Hospital Long Island, followed 310 patients. Results showed a 10-year overall survival rate of 84% and a relapse-free survival rate of 90%. Cumulative grade 3 gastrointestinal or genitourinary toxicities were low, and no grade 4-5 events were observed, establishing SBRT's long-term safety and efficacy.
5/12/2026
The Baltimore Sun /The Tribune Content Agency
Scientists at NYU Grossman School of Medicine have identified a protein, HOXD13, that acts as a 'master switch' driving melanoma growth and survival. According to Pietro Berico, a postdoctoral research fellow at NYU Grossman School of Medicine and Perlmutter Â鶹ÊÓƵapp Center, the transcription factor helps tumors grow new blood vessels and prevents immune T cells from entering the tumor. The research, published in Â鶹ÊÓƵapp Discovery, found that blocking the protein's activity allowed more T cells to enter the tumor, suggesting a potential new therapeutic approach for the aggressive cancer.
Also reporting was: , , , , , , , , , , ,
5/12/2026
